Pediatric Shock: An Uncommon and Underrecognized Etiology

Kim R. Derespina; Shubhi Kaushik; Shivanand S. Medar

doi:10.1055/s-0039-1700964

Journal of Pediatric Intensive Care, Table of Contents

J Pediatr Intensive Care 2020; 09(03): 210-212
DOI: 10.1055/s-0039-1700964

Case Report

Georg Thieme Verlag KG Stuttgart · New York

Pediatric Shock: An Uncommon and Underrecognized Etiology

Kim R. Derespina

¹Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, New York, United States

,

Shubhi Kaushik

¹Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, New York, United States

,

Shivanand S. Medar

¹Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, New York, United States

› Author Affiliations

Abstract

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a well-known disease entity. Kawasaki shock syndrome (KSS), on the other hand, is less well recognized and has been reported in small single-center international studies and case reports. We report a case in the United States of an 11-year-old male with multiorgan failure and shock, presumed to be secondary to toxic shock but later diagnosed with KSS, an underrecognized entity in the US and review the literature. KSS should be considered in a critically ill child with unexplained shock.

Keywords

Kawasaki disease - Kawasaki shock syndrome - erythema

Full Text

References

References
1 Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 1967; 16 (03) 178-222
2 McCrindle BW, Rowley AH, Newburger JW. , et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017; 135 (17) e927-e999
3 Kanegaye JT, Wilder MS, Molkara D. , et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009; 123 (05) e783-e789
4 Gámez-González LB, Murata C, Muñoz-Ramírez M, Yamazaki-Nakashimada M. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Eur J Pediatr 2013; 172 (03) 337-342
5 Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glodé MP. Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics 2008; 122 (04) e786-e790
6 Taddio A, Rossi ED, Monasta L. , et al. Describing Kawasaki shock syndrome: results from a retrospective study and literature review. Clin Rheumatol 2017; 36 (01) 223-228
7 Kuo CC, Lee YS, Lin MR. , et al. Characteristics of children with Kawasaki disease requiring intensive care: 10 years' experience at a tertiary pediatric hospital. J Microbiol Immunol Infect 2018; 51 (02) 184-190
8 Lin MT, Fu CM, Huang SK, Huang SC, Wu MH. Population-based study of Kawasaki disease shock syndrome in Taiwan. Pediatr Infect Dis J 2013; 32 (12) 1384-1386
9 Ma L, Zhang YY, Yu HG. Clinical manifestations of Kawasaki disease shock syndrome. Clin Pediatr (Phila) 2018; 57 (04) 428-435
10 Yang HF, Chen WL, Chang CN, Chen SJ, Fan HC. Kawasaki disease shock syndrome: case report. Paediatr Int Child Health 2016; 36 (01) 76-78
11 Dionne A, Dahdah N. Myocarditis and Kawasaki disease. Int J Rheum Dis 2018; 21 (01) 45-49
12 Best D, Millar J, Kornilov I. , et al. Extracorporeal membrane oxygenation for Kawasaki disease: two case reports and the Extracorporeal Life Support Organization experience 1999-2015. Perfusion 2017; 32 (07) 609-612